1 |
Butris N, Tang E, Pivetta B, et al. The prevalence and risk factors of sleep disturbances in surgical patients: a systematic review and meta-analysis[J]. Sleep Med Rev, 2023, 69: 101786.
|
2 |
Öner Ö, Ecevit MC, Gökmen AN. A bibliometric analysis of obstructive sleep apnea and anesthesia[J]. Medicine, 2023, 102(17): e32993.
|
3 |
Lu HF, He F, Huang Y, et al. Different doses of dexmedetomidine reduce postoperative sleep disturbance incidence in patients under general anesthesia by elevating serum neurotransmitter levels[J]. Crit Rev Immunol, 2024, 44(6): 63-73.
|
4 |
van Zuylen ML, Meewisse AG, Ten Hoope W, et al. Effects of surgery and general anaesthesia on sleep-wake timing: CLOCKS observational study[J]. Anaesthesia, 2022, 77(1): 73-81.
|
5 |
Lei M, Zhang P, Liu YF, et al. Propofol and sufentanil may affect the patients' sleep quality independently of the surgical stress response: a prospective nonrandomized controlled trial in 1033 patients' undergone diagnostic upper gastrointestinal endoscopy[J]. BMC Anesthesiol, 2017, 17(1): 53.
|
6 |
Ayuse T, Kurata S, Mishima G, et al. Influence of general anesthesia on the postoperative sleep cycle in patients undergoing surgery and dental treatment: a scoping review on the incidence of postoperative sleep disturbance[J]. J Dent Anesth Pain Med, 2023, 23(2): 59-67.
|
7 |
刘 影, 李劲草, 薛 瑞, 等. 大麻二酚配伍褪黑素改善大、小鼠失眠和昼夜节律紊乱作用及机制[J]. 中国药理学与毒理学杂志, 2023, 37(2): 81-90. DOI: 10.3867/j.issn.1000-3002.2023.02.001
|
8 |
Smith MT, Haythornthwaite JA. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature[J]. Sleep Med Rev, 2004, 8(2): 119-32.
|
9 |
Smegal LF, Vedmurthy P, Ryan M, et al. Cannabidiol treatment for neurological, cognitive, and psychiatric symptoms in sturge-weber syndrome[J]. Pediatr Neurol, 2023, 139: 24-34.
|
10 |
Patke A, Young MW, Axelrod S. Molecular mechanisms and physiological importance of circadian rhythms[J]. Nat Rev Mol Cell Biol, 2020, 21(2): 67-84.
|
11 |
Clarkson SJ, Yayac MF, Rondon AJ, et al. Melatonin does not improve sleep quality in a randomized placebo-controlled trial after primary total joint arthroplasty[J]. J Am Acad Orthop Surg, 2022, 30(2): e287-94.
|
12 |
Anderson LL, Hawkins NA, Yip KL, et al. Preclinical evidence for a drug-drug interaction between cannabinol and melatonin[J]. Basic Clin Pharmacol Toxicol, 2025, 136(1): e14120.
|
13 |
Kirkland AE, Fadus MC, Gruber SA, et al. A scoping review of the use of cannabidiol in psychiatric disorders[J]. Psychiatry Res, 2022, 308: 114347.
|
14 |
Koch M, Dehghani F, Habazettl I, et al. Cannabinoids attenuate norepinephrine-induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N-acetyltransferase activity without involvement of cannabinoid receptors[J]. J Neurochem, 2006, 98(1): 267-78.
|
15 |
Korf HW. Photoneuroendocrine, circadian and seasonal systems: from photoneuroendocrinology to circadian biology and medicine[J]. Cell Tissue Res, 2024, Online ahead of print.
|
16 |
Dispersyn G, Pain L, Touitou Y. Propofol anesthesia significantly alters plasma blood levels of melatonin in rats[J]. Anesthesiology, 2010, 112(2): 333-7.
|
17 |
Rosenblum Y, Bogdány T, Nádasy LB, et al. Aperiodic neural activity distinguishes between phasic and tonic REM sleep[J]. J Sleep Res, 2024: e14439.
|
18 |
Kharas N, Chelaru MI, Eagleman S, et al. NREM sleep improves behavioral performance by desynchronizing cortical circuits[J]. Science, 2024, 386(6724): 892-7.
|
19 |
Challet E, Gourmelen S, Pevet P, et al. Reciprocal relationships between general (Propofol) anesthesia and circadian time in rats[J]. Neuropsychopharmacology, 2007, 32(3): 728-35.
|
20 |
Lee RD, Larson O, Dhaliwal S, et al. Comparative analysis of sleep physiology using qualitative and quantitative criteria for insomnia symptoms[J]. Sleep, 2024: zsae301.
|
21 |
Cankar N, Beschorner N, Tsopanidou A, et al. Sleep deprivation leads to non-adaptive alterations in sleep microarchitecture and amyloid-β accumulation in a murine Alzheimer model[J]. Cell Rep, 2024, 43(11): 114977.
|
22 |
Scott AJ, Webb TL, Martyn-St James M, et al. Improving sleep quality leads to better mental health: a meta-analysis of randomised controlled trials[J]. Sleep Med Rev, 2021, 60: 101556.
|
23 |
McCarter SJ, Hagen PT, St Louis EK, et al. Physiological markers of sleep quality: a scoping review[J]. Sleep Med Rev, 2022, 64: 101657.
|
24 |
Pavlova MK, Latreille V. Sleep disorders[J]. Am J Med, 2019, 132(3): 292-9.
|
25 |
Lafaye G, Desterke C, Marulaz L, et al. Cannabidiol affects circadian clock core complex and its regulation in microglia cells[J]. Addict Biol, 2019, 24(5): 921-34.
|
26 |
Uzbay T, Shahzadi A. A comprehensive analysis of propofol abuse and addiction and neuropharmacological aspects: an updated review[J]. Korean J Anesthesiol, 2025, 78(2): 91-104.
|
27 |
Britch SC, Babalonis S, Walsh SL. Cannabidiol: pharmacology and therapeutic targets[J]. Psychopharmacology, 2021, 238(1): 9-28.
|
28 |
San-juan D, Chiappa KH, Cole AJ. Propofol and the electro-encephalogram[J]. Clin Neurophysiol, 2010, 121(7): 998-1006.
|
29 |
Shilovsky GA, Putyatina TS, Morgunova GV, et al. A crosstalk between the biorhythms and gatekeepers of longevity: dual role of glycogen synthase kinase-3[J]. Biochemistry, 2021, 86(4): 433-48.
|
30 |
Li HX, Meng H, Xu M, et al. BMAL1 regulates osteoblast differentiation through mTOR/GSK3β/β-catenin pathway[J]. J Mol Endocrinol, 2023, 70(4): e220181.
|
31 |
Sagredo O, Ruth Pazos M, Satta V, et al. Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease[J]. J Neurosci Res, 2011, 89(9): 1509-18.
|
32 |
Blando S, Raffaele I, Chiricosta L, et al. Cannabidiol promotes neuronal differentiation using Akt and erk pathways triggered by Cb1 signaling[J]. Molecules, 2022, 27(17): 5644.
|
33 |
Hamelink C, Hampson A, Wink DA, et al. Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity[J]. J Pharmacol Exp Ther, 2005, 314(2): 780-8.
|